No abstract available
MeSH terms
-
Antibodies, Monoclonal, Murine-Derived / therapeutic use*
-
Combined Modality Therapy
-
Female
-
Graft vs Host Disease / drug therapy
-
Hematopoietic Stem Cell Transplantation / adverse effects*
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Middle Aged
-
Plasmapheresis / methods*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
-
Rituximab
-
Thrombotic Microangiopathies / etiology
-
Thrombotic Microangiopathies / therapy*
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
Immunosuppressive Agents
-
Rituximab